Cabozantinib,Nivolumab,Ipilimumab
bms,exelixis
['nivo', 'triplet,(-triplete)', 'sequence,(-consequence)', 'pdigree']
do these data challenge the #pdigree trial? given cons of triplet, key sequencing questions still remain and perhaps more important. the sequence of ipi-nivo followed by cabo-nivo is relevant for #kidneycancer as long as we still use ipi-nivo. #esmo22 6/n 
I treat & research GU cancers @UTSW Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Tweets=my opinions ASCO: https://t.co/Whk29PATXe